During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to an advanced prostate cancer podium session. Dr. Alejandro Sanchez presented the results ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...

Several ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety, and efficiency in healthcare.

Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation or chemotherapy.

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

The 35-year-old left-hander always flashes back to losing his dad to colon cancer at the start of his sophomore year at his ...

Black people are not immune to the dangers of UV radiation, and should take steps to protect their skin year-round, including wearing sunscreen and staying in the shade during peak sun hours.

From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...